2002
DOI: 10.1378/chest.121.4.1051
|View full text |Cite
|
Sign up to set email alerts
|

A Comparison of the Validity of Different Diagnostic Tests in Adults With Asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

4
121
1
4

Year Published

2005
2005
2020
2020

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 167 publications
(134 citation statements)
references
References 26 publications
(37 reference statements)
4
121
1
4
Order By: Relevance
“…The assessment of airway inflammation by quantification of induced sputum eosinophils and exhaled nitric oxide measurement offers low sensitivity but high specificity and is predictive of response to corticosteroid therapy [48,49]. The correlation between exhaled nitric oxide fraction (FeNO) and sputum eosinophilia is good in corticosteroid-naive patients, but this relationship is weaker once patients are treated [50].…”
Section: Question 10mentioning
confidence: 99%
“…The assessment of airway inflammation by quantification of induced sputum eosinophils and exhaled nitric oxide measurement offers low sensitivity but high specificity and is predictive of response to corticosteroid therapy [48,49]. The correlation between exhaled nitric oxide fraction (FeNO) and sputum eosinophilia is good in corticosteroid-naive patients, but this relationship is weaker once patients are treated [50].…”
Section: Question 10mentioning
confidence: 99%
“…We could not assess whether assessment of peak expiratory flow variability added any value to the tests assessed as these data were not collected. However, abnormal peak flow variability is an insensitive test in patients with symptomatic asthma, 13 suggesting that it would not. Second, there may be differences in symptoms and treatment levels between patients who replied to our study invitation and those who did not; however, the rate of airway abnormality seen in our study is similar to that observed in others.…”
mentioning
confidence: 99%
“…From an investigational point of view, all techniques have been widely applied to more or less all disease conditions in order to gain information on the pathogenesis of and, ultimately, improve the ability to diagnose and treat respiratory disorders. From a clinical point of view, each technique has been proposed in selected clinical scenarios [7,[10][11][12][13][14][16][17][18][19]. The clinical application of one of the BAL biomarkers, i.e.…”
mentioning
confidence: 99%
“…The clinical application of one of the BAL biomarkers, i.e. cell differential count, is now widely accepted and recommended in clinical guidelines as a diagnostic tool for sarcoidosis and idiopathic pulmonary fibrosis [8,9], while other biomarkers, induced sputum cell counts and FeNO values are considered useful additional tools in the management of asthma [6,7,[10][11][12][13][14][15][16][17][18][19][20]. In contrast, the determination of molecular markers in EBC is still awaiting an accepted clinical application.…”
mentioning
confidence: 99%